Compare PLYX & OTGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLYX | OTGA |
|---|---|---|
| Founded | 2014 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.3M | 295.1M |
| IPO Year | N/A | N/A |
| Metric | PLYX | OTGA |
|---|---|---|
| Price | $5.45 | $10.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 21.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.20 | $9.97 |
| 52 Week High | $8.15 | $10.12 |
| Indicator | PLYX | OTGA |
|---|---|---|
| Relative Strength Index (RSI) | 52.51 | 53.57 |
| Support Level | $2.37 | $10.03 |
| Resistance Level | $7.43 | $10.09 |
| Average True Range (ATR) | 1.11 | 0.02 |
| MACD | 0.22 | 0.00 |
| Stochastic Oscillator | 59.79 | 33.33 |
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.
OTG Acquisition Corp I is a newly organized blank check company.